Physiometrix' 10-K includes 'going concern'

Physiometrix (North Billerica, Massachusetts) said that its 2004 financial statements included in the company's Form 10-K, filed with the Securities and Exchange Commission on March 31, contained a "going concern" qualification from its auditors.

The announcement, it said, is made to comply with Nasdaq rule requiring disclosures of such an opinion. The uncertainty described is based upon the company's cash balance as of Dec. 31, which, it said, "was not sufficient to fund projected operations over the next year and does not take into account any potential future cash inflows."

Physiometrix makes non-invasive medical products, based on gel materials, signal-processing electronic technologies and software, for use in anesthesia monitoring during surgery.

AHRQ council to update progress

The National Advisory Council of the Agency for Healthcare Research and Quality (AHRQ; Rockville, Maryland) will meet on Friday, from 9 a.m. to noon, at the Hubert H. Humphrey Building in Washington.

The meeting, which is open to the public, will begin with an update on the status of AHRQ's current research, programs and initiatives. It also will discuss developing a core infrastructure for action and will hear from Mark McClellan, MD, administrator of the Centers for Medicare & Medicaid Services (CMS; Baltimore) on the quality strategy at CMS.

AHRQ provides advice to the secretary of Health and Human Services and to the director of the AHRQ on matters related to its customers and health services researchers.

No prior registration is required for the Friday meeting.